Corpus Intelligence IC Memo — WILLIAM BEAUMONT HOSPITAL - TROY 2026-04-26 05:25 UTC
IC Memo — WILLIAM BEAUMONT HOSPITAL - TROY
Investment Committee Memorandum | MI | 484 beds | Grade C | EBITDA uplift $55.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

WILLIAM BEAUMONT HOSPITAL - TROY

CCN 230269 | OAKLAND, MI | 484 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

WILLIAM BEAUMONT HOSPITAL - TROY is a 484-bed suburban community hospital in OAKLAND, MI with $747.4M in net patient revenue and a 2.3% operating margin. The hospital serves a payer mix of 33.6% Medicare, 2.5% Medicaid, and 63.9% commercial.

Thesis: Undervalued. Our ML models identify $55.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 2.3% to 9.7% (+736bps).

Net Revenue HCRIS$747.4M
Current EBITDA COMPUTED$17.5M
Operating Margin COMPUTED2.3%
Occupancy HCRIS84.2%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS21.5%
Distress Probability ML40.0%

2. Market Context & Competitive Position

163
MI Hospitals
-5.2%
State Median Margin
25
Comparable Hospitals

MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of 2.3% places it above the state median. Among 25 size-comparable peers (242-968 beds), the median margin is -7.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (242-968), prioritizing same-state peers. 25 hospitals in the comp set.

HospitalStateBedsRevenueMargin
WILLIAM BEAUMONT HOSPITAL - TR (Target)MI484$747.4M2.3%
UNIV OF MI HOSPITALS & HLTH CTMI951$4.62B-1.4%
HENRY FORD HOSPITALMI670$2.32B-14.8%
BRONSON METHODIST HOSPITALMI439$1.06B-1.4%
TRINITY HEALTH ANN ARBORMI475$1.00B-1.0%
EDWARD W. SPARROW HOSPITALMI425$936.1M-24.5%
ASCENSION ST JOHN HOSPITALMI556$929.1M-9.6%
ASCENSION PROVIDENCE HOSPITALMI527$849.3M-6.5%
MUNSON MEDICAL CENTERMI401$710.9M-7.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $55.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$15.7M+210bp18mo
Cost to Collect4.5%2.5%$14.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$14.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$9.1M+122bp9mo
Clean Claim Rate88.0%96.0%$478K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$15.7M
Cost to Collect
$14.9M
Denial Rate Reduction
$14.8M
A/R Days Reduction
$9.1M
Clean Claim Rate
$478K
Total EBITDA Uplift$55.0M
Current EBITDA$17.5M
+ RCM Uplift+$55.0M
Pro Forma EBITDA$72.5M
Current Margin2.3%
Pro Forma Margin9.7%
WC Released (1x)$28.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$26.9M$665.5M24.73x90.0%
Base (11x exit)10.0x11.0x$26.9M$740.8M27.52x94.1%
Bull Case9.0x11.0x$24.2M$931.1M38.44x107.5%
Bull (12x exit)9.0x12.0x$24.2M$1.02B42.23x111.4%
Bear Case11.0x10.0x$29.6M$381.7M12.89x66.8%
Bear (11x exit)11.0x11.0x$29.6M$429.5M14.51x70.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 25 hospitals with 242-968 beds
  • Same-state prioritization (n=26)
  • Comp margins: P25=-10.5% / P50=-7.2% / P75=-3.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.